Allmed Medical Products Co., Ltd

SZSE:002950.SZ

9.17 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Revenue 758.657876.216868.423830.169741.806732.313591.568612.076814.6421,143.341932.7331,141.389993.039598.302830.658676.013820.582745.753833.221,657.967597.558640.889616.897580.567514.109579.756545.582495.787406.387438.072
Cost of Revenue 527.147604.568638.467612.328531.565591.229433.53441.88542784.312640.9709.941676.695375.444625.431477.11566.067497.31471.828881.751383.985415.529399.336390.485349.993375.306383.072348.516284.343371.173
Gross Profit 231.51271.648229.955217.841210.242141.084158.038170.196272.642359.029291.834431.448316.344222.859205.227198.903254.515248.443361.392776.216213.573225.36217.561190.082164.116204.45162.51147.271122.04466.899
Gross Profit Ratio 0.3050.310.2650.2620.2830.1930.2670.2780.3350.3140.3130.3780.3190.3720.2470.2940.310.3330.4340.4680.3570.3520.3530.3270.3190.3530.2980.2970.30.153
Reseach & Development Expenses 29.82148.51719.04618.71418.4616.94222.02416.21321.82462.09914.28114.08217.27236.47618.3218.96430.81768.81320.16119.4629.6914.77117.439.05918.45319.60211.1647.34911.6240
General & Administrative Expenses 74.86-160.474186.842-37.83965.033-193.839218.481-56.09790.8158.323234.98-33.492102.927-152.985185.981-39.59172.778-125.60859.834-25.48552.467-99.47855.487-24.69448.303-82.37242.24141.36537.7580
Selling & Marketing Expenses 23.998-118.69649.71324.7618.74920.59313.7068.66322.736.50225.14333.39418.75827.94914.79817.64614.08-70.09447.22629.74131.33234.4331.00235.62129.06235.86329.01125.57622.420
SG&A 98.858-279.169236.55581.25183.07175.504232.187-47.434113.5466.754260.123-0.098121.685-125.036200.779-21.94686.858-195.703107.064.25783.799-65.04986.48810.92777.365-46.50971.25266.94160.1770
Other Expenses -9.815375.189-120.5290.226-0.685-81.3660.0130.528-0.017-27.72-143.782136.39-5.0430.753-1.053-0.037-0.0470.238-1.1260.498-2.7267.029-2.2160.285-1.487-0.519-1.1660.509-0.0350
Operating Expenses 118.864144.536135.07399.738102.216173.812119.858100.498135.347101.134130.622150.374133.914152.63996.30490.14584.1543.63119.471107.08483.453113.98790.29285.04392.29493.179.48274.41173.6940.146
Operating Income 112.647127.11294.883118.102108.026-32.728-0.00447.628149.456257.89520.918159.257196.322104.73108.103148.413144.628213.795299.158722.118106.711123.12127.23670.60569.583100.76871.29254.45451.08166.899
Operating Income Ratio 0.1480.1450.1090.1420.146-0.045-00.0780.1830.2260.0220.140.1980.1750.130.220.1760.2870.3590.4360.1790.1920.2060.1220.1350.1740.1310.110.1260.153
Total Other Income Expenses Net -1.025-3.2270.44-0.0566.6364.3175.8190.528-0.167-22.261-123.926-1.701-1.5990.753-1.053-0.037-0.0470.238-1.1260.498-2.7267.029-2.2160.285-1.487-0.519-1.1660.509-0.0350.146
Income Before Tax 111.622123.88595.323125.667111.959-37.2270.00948.156149.288235.635-103.008157.556194.723105.483107.05148.376144.581214.033298.031722.616103.984130.15125.0270.8968.096100.24970.12654.96351.04667.045
Income Before Tax Ratio 0.1470.1410.110.1510.151-0.05100.0790.1830.206-0.110.1380.1960.1760.1290.2190.1760.2870.3580.4360.1740.2030.2030.1220.1320.1730.1290.1110.1260.153
Income Tax Expense 24.96920.77216.92127.36620.53512.4689.82220.1522.38427.742-9.74926.41635.8544.3916.1825.71527.24514.28948.779101.63713.49722.64719.10114.93813.27214.13416.1399.24310.55813.276
Net Income 86.503103.51478.16993.11893.879-40.005-6.63429.155127.885209.918-93.259132.38157.718102.08391.363121.465116.305198.373247.508620.45191.195107.866106.13256.41755.39886.85954.48645.34141.09553.356
Net Income Ratio 0.1140.1180.090.1120.127-0.055-0.0110.0480.1570.184-0.10.1160.1590.1710.110.180.1420.2660.2970.3740.1530.1680.1720.0970.1080.150.10.0910.1010.122
EPS 0.140.1660.130.150.15-0.063-0.0110.0460.20.33-0.150.210.250.160.140.190.180.310.390.980.140.170.250.0960.0950.150.0970.0810.0730.094
EPS Diluted 0.140.1660.130.150.15-0.063-0.0110.0460.20.33-0.150.210.250.160.140.190.180.310.390.980.140.170.250.0960.0950.150.0970.0810.0730.094
EBITDA 116.479128.282105.25190.414178.12428.45172.182107.853212.419239.31825.901211.31249.167143.628150.514190.439182.202298.534317.141705.239131.308164.069166.072101.789109.589140.25109.17665.29659.1070
EBITDA Ratio 0.1540.1460.1210.2290.240.0390.1220.1760.2610.2090.0280.1850.2510.240.1810.2820.2220.40.3810.4250.220.2560.2690.1750.2130.2420.20.1320.1450